Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Karsten B. Seiber"'
Autor:
Dongnhu T Truong, Julio Molineros, Yanqing Chen, Meijian Guan, Amy Hart, Bryce Keyes, Karsten B. Seiber, Shuwei Li, Dawn Waterworth, Mary Helen Black
Publikováno v:
The Journal of Immunology. 208:60.03-60.03
Background Dupilumab is the only approved biologic used to treat moderate to severe atopic dermatitis (AD) but has a non-response rate of 55–60%. This suggests underlying heterogeneity in AD etiology, requiring alternate therapies for patients. Stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::468e931420e1fed8f18bcce1489b31e2
https://doi.org/10.4049/jimmunol.208.supp.60.03
https://doi.org/10.4049/jimmunol.208.supp.60.03
